-
Dinapsoline is a drug
developed for the
treatment of Parkinson's disease, that acts as a
selective full
agonist at the
dopamine D1 receptor.
Gulwadi AG...
-
including the
selective D1 full
agonist compounds dihydrexidine and
dinapsoline which have been
researched for the
treatment of Parkinson's disease,...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
- derivatives: A-77636 A-86929
Adrogolide (ABT-431, DAS-431)
Dihydrexidine Dinapsoline Dinoxyline Doxanthrine Phenethylamines: BCO-001
Deoxyepinephrine (N-methyldopamine...
